Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Cash Flow-to-Debt Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥110.78 Million could theoretically repay 0% of its total liabilities (CN¥2.56 Billion) in one year. Explore long-term investment intensity of Tianjin Zhongxin Pharmaceutical Group Co to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Tianjin Zhongxin Pharmaceutical Group Corp Ltd across 24 annual periods. Also explore 600329 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for Tianjin Zhongxin Pharmaceutical Group Corp Ltd. For market capitalisation and broader financial context, see Tianjin Zhongxin Pharmaceutical Group Co market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥924.67 Million | CN¥2.92 Billion | ▲ +65.0% |
| 2023 | 0.19x | CN¥688.49 Million | CN¥3.58 Billion | ▲ +2.2% |
| 2022 | 0.19x | CN¥677.25 Million | CN¥3.61 Billion | ▼ -43.7% |
| 2021 | 0.33x | CN¥852.40 Million | CN¥2.55 Billion | ▲ +16.0% |
| 2020 | 0.29x | CN¥671.42 Million | CN¥2.33 Billion | ▲ +34.7% |
| 2019 | 0.21x | CN¥495.49 Million | CN¥2.32 Billion | ▲ +25.1% |
| 2018 | 0.17x | CN¥350.14 Million | CN¥2.05 Billion | ▲ +8679.3% |
| 2017 | 0.00x | CN¥-3.97 Million | CN¥2.00 Billion | ▼ -101.0% |
| 2016 | 0.20x | CN¥419.90 Million | CN¥2.06 Billion | ▲ +11.1% |
| 2015 | 0.18x | CN¥360.58 Million | CN¥1.96 Billion | ▲ +59.4% |
| 2014 | 0.12x | CN¥286.85 Million | CN¥2.49 Billion | ▲ +45.0% |
| 2013 | 0.08x | CN¥213.44 Million | CN¥2.69 Billion | ▲ +717.4% |
| 2012 | 0.01x | CN¥20.81 Million | CN¥2.14 Billion | ▼ -89.2% |
| 2011 | 0.09x | CN¥173.88 Million | CN¥1.94 Billion | ▲ +12.9% |
| 2010 | 0.08x | CN¥139.04 Million | CN¥1.75 Billion | ▲ +79.0% |
| 2009 | 0.04x | CN¥83.41 Million | CN¥1.88 Billion | ▼ -43.8% |
| 2008 | 0.08x | CN¥155.77 Million | CN¥1.97 Billion | ▲ +734.4% |
| 2007 | 0.01x | CN¥20.13 Million | CN¥2.13 Billion | ▲ +170.7% |
| 2006 | -0.01x | CN¥-28.08 Million | CN¥2.10 Billion | ▼ -110.8% |
| 2005 | 0.12x | CN¥261.91 Million | CN¥2.11 Billion | ▲ +2310.9% |
| 2004 | 0.01x | CN¥10.50 Million | CN¥2.04 Billion | ▼ -86.8% |
| 2003 | 0.04x | CN¥76.57 Million | CN¥1.96 Billion | ▼ -72.5% |
| 2002 | 0.14x | CN¥187.60 Million | CN¥1.32 Billion | ▲ +6.3% |
| 2001 | 0.13x | CN¥157.73 Million | CN¥1.18 Billion | — |